Clinical Trial Update: A Study to Compare a New Long-Acting Insulin (LY2605541) and Human Insulin NPH in Participants With Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial comparing a new long-acting insulin LY2605541 to human insulin NPH in adults with Type 2 diabetes; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Human Insulin NPH (insulin isophane)
• LY2605541

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2018-05-03